Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page
- Check6 days agoChange DetectedThe page gains new study metadata and documentation, including sponsor and investigators, collaborators, and links to the Study Protocol and SAP, as well as IPD sharing information and related MeSH terms.SummaryDifference73%

- Check13 days agoChange DetectedNo additions or deletions were provided in the data, so there is no change to evaluate. The study details content remains as documented on the page.SummaryDifference0.0%

- Check21 days agoChange DetectedThe Study Details page gains recruitment status and guidance sections (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0; the existing 'Intervention/Treatment' section is removed and the prior v3.5.5 revision note is eliminated.SummaryDifference0.4%

- Check28 days agoChange DetectedRevision label on the page updated from v3.5.4 to v3.5.5, reflecting a recent site deployment.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4. This appears to be a minor metadata/template update with no effect on the study details or user-facing information.SummaryDifference0.0%

- Check63 days agoChange DetectedThe site revision has been updated to v3.5.3, replacing the previous v3.5.2. This appears to be a minor platform release and does not alter the study information or its presentation on the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.